Catalyst Wire Dossier Catalyst Wire Dossier

tipepidine

tipepidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tipepidine, covering 2019-03-19 to 2019-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial [Phase 1, Phase 2]

See pricing